Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro.
Several reverse transcriptase polymerase chain reaction (RT-PCR) assays have been described for the detection of circulating tumour cells in blood and bone marrow. Target mRNA sequences for this purpose are the cytokeratins (CK) 19 and 20, the carcinoembryonic antigen (CEA), and the prostate-specific antigen messages. In this study, we investigated biological factors influencing the specificity of the CK19 and CEA RT-PCR assays. Bone marrow, granulocyte colony-stimulating factor (G-CSF)-mobilized blood stem cells and peripheral blood samples obtained from healthy volunteers (n = 15; CEA n = 7), from patients with epithelial (n = 29) and haematological (n = 23) cancer and from patients with chronic inflammatory diseases (n = 16) were examined. Neither CEA nor cytokeratin 19 messages could be amplified from bone marrow samples from healthy subjects and from patients with haematological malignancies. In contrast, specimens from patients with inflammatory diseases scored positive up to 60%. To investigate the influence of inflammation on target mRNA expression, haemopoietic cells were cultured with and without cytokine stimulation in vitro. CK19 messages could be easily detected in cultured marrow cells without further stimulation, CEA messages only after gamma-interferon (gamma-INF) stimulation. In contrast, G-CSF-mobilized peripheral blood stem cells were positive for CK19 messages only after stem cell factor (SCF) or interleukin stimulation. We conclude that transcription of so-called tissue-specific genes is inductible in haemopoietic tissues under certain conditions. These factors have to be considered in future applications of RT-PCR for the detection of minimal residual disease.
Jung
R
R
Department of Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany.
Krüger
W
W
Hosch
S
S
Holweg
M
M
Kröger
N
N
Gutensohn
K
K
Wagener
C
C
Neumaier
M
M
Zander
A R
AR
D000008:Abdominal Neoplasms / Q000097:blood; D001853:Bone Marrow / Q000737:chemistry; D002272:Carcinoembryonic Antigen / Q000032:analysis / Q000097:blood; D016207:Cytokines / Q000494:pharmacology*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells / Q000737:chemistry / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000097:blood; D007633:Keratins / Q000032:analysis / Q000097:blood; D007937:Leukapheresis; D009360:Neoplastic Cells, Circulating / Q000737:chemistry* / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D013268:Stimulation, Chemical; D017154:Stromal Cells / Q000737:chemistry
D002272:Carcinoembryonic Antigen; D016207:Cytokines; D012333:RNA, Messenger; D016179:Granulocyte Colony-Stimulating Factor; D007633:Keratins